Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

44 results
Display

Sarcomatoid hepatocellular carcinoma with mixed osteoclast-like giant cells and chondroid differentiation

Lee KB

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Gastric Yolk Sac Tumor: A Case Report and Review of the Literature

Kim YS, Kim SH, Seong JK, Lee BS, Jeong HY, Song KS

Gastric yolk sac tumors are extremely rare and their prognosis is poor; most patients have widespread metastases at the time of diagnosis. The treatment of gastric yolk sac tumors consists...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A case of focal nodular hyperplasia with growth progression during pregnancy

Kim MJ, Han SY, Baek YH, Lee SW, Kwon HJ

Focal nodular hyperplasia (FNH) is the second most common benign solid tumor of the liver and is usually found in young females. In FNH, spontaneous bleeding or rupture rarely occurs...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Composite liver tumors: A radiologic-pathologic correlation

Nayyar M, Imagawa DK, Tirkes T, Demirjian , Houshyar R, Sandrasegaran K, Nangia CS, Seery T, Bhargava P, Choi JI, Lall C

Bi-phenotypic neoplasm refers to tumors derived from a common cancer stem cell with unique capability to differentiate histologically into two distinct tumor types. Bi-phenotypic hepatocellular carcinoma-cholangiocarcinoma (HCC-CC), although a rare...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Hepatic Metastasis of Gastric Hepatoid Adenocarcinoma Mistaken for Primary Hepatocellular Carcinoma

Moon JY, Kim GH, Cheong JH, Lee BE, Ryu DY, Song GA

Gastric hepatoid adenocarcinoma is a special type of gastric carcinoma, which produces AFP. We report a case of an metastatic gastric hepatoid adenocarcinoma mistaken for primary hepatocellular carcinoma (HCC). A...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Peri-Transplant Change in AFP Level: a Useful Predictor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation

Yoo T, Lee KW, Yi NJ, Choi YR, Kim H, Suh SW, Jeong JH, Lee JM, Suh KS

Pretransplant alpha-fetoprotein (AFP) is a useful tumor marker predicting recurrence of hepatocellular carcinoma (HCC). Little is known, however, about the relationship between changes in AFP concentration and prognosis. This study...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hepatocellular Carcinoma in the Elderly: Clinical Characteristics, Treatment, Survival Analysis in Korean Patients Older than 70 Years

Kim YJ, Jang BK, Kim ES, Chung WJ, Park KS, Cho KB, Hwang JS

The prevalence of hepatocellular carcinoma (HCC) has increased in recent years. However, HCC remains poorly characterized in elderly patients, and comprehensive data are limited. This study aimed to investigate the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Bone marrow metastasis presenting as bicytopenia originating from hepatocellular carcinoma

Hong YM, Yoon KT, Cho M, Kang DH, Kim HW, Choi CW, Park SB, Heo J, Woo HY, Lim W, Bakhtiar UI Islam SM

The bone is a common site for metastasis in hepatocellular carcinoma (HCC). However, bone marrow metastasis from HCC is rarely reported, and its frequency is unclear. Here we report a...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Alpha-Fetoprotein Values in Maternal Serum and Amniotic Fluid for Prenatal Screening of Genetic Disorders

Kim CK, Yang YH

Prenatal alpha-fetoprotein screening may serve as an index of suspicion of many congenital anomalies of the fetus including neural tube defect and aneuploid fetus. This study was undertaken to determine...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016

Yu SJ

Many guidelines for hepatocellular carcinoma (HCC) have been published and updated globally. In contrast to other cancers, there is a range of treatment options for HCC involving several multidisciplinary care...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapy

Park JG

BACKGROUND/AIMS: Sorafenib is currently the sole molecular targeted agent that improves overall survival in advanced hepatocellular carcinoma (HCC). Despite the efficacy of sorafenib, the response rate varies in patients with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
NADPH Oxidase 1 and NADPH Oxidase 4 Have Opposite Prognostic Effects for Patients with Hepatocellular Carcinoma after Hepatectomy

Ha SY, Paik YH, Yang JW, Lee MJ, Bae H, Park CK

BACKGROUND/AIMS: Nicotinamide adenine dinucleotide phosphate oxidase (NOX)-mediated reactive oxygen species contribute to various liver diseases, including hepatocellular carcinoma (HCC). Uncertainties remain regarding the prognostic relevance of NOX1 and NOX4 protein...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Optimal Cut-off Value of PIVKA-II for Diagnosis of Hepatocellular Carcinoma: Using ROC Curve

Kim MJ, Bae KW, Seo PJ, Jeong IK, Kim JH, Lee BH, Bang KT, Kim DW, Song IH

  • KMID: 760672
  • Korean J Hepatol.
  • 2006 Sep;12(3):404-411.
BACKGROUND/AIMS: Protein induced by vitamin K absence or antagonist-II (PIVKA-II), also known as des-carboxyprothrombin (DCP), can be used as an alternative tool to alpha-fetoprotein (AFP) for surveillance of hepatocellular...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expression Characteristics of KAI1 and Vascular Endothelial Growth Factor and Their Diagnostic Value for Hepatocellular Carcinoma

Zhang W, Zhao CG, Sun HY, Zheng WE, Chen H

BACKGROUND/AIMS: We tried to investigate the expression characteristics of KAI1, a suppressor of wide-spectrum tumor metastasis, and vascular endothelial growth factor (VEGF), the most common angiogenesis factor, and then to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The retrospective cohort study for survival rate in patients with advanced hepatocellular carcinoma receiving radiotherapy or palliative care

Eun HS, Kim MJ, Kim HJ, Ko KH, Moon HS, Lee ES, Kim SH, Lee HY, Lee BS

BACKGROUND/AIMS: This study was conducted to investigate the assessment of treatment efficacy of radiotherapy (RT) and other therapeutic modalities compared with palliative care only for treatment with advanced hepatocellular carcinoma...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A lexicon for hepatocellular carcinoma surveillance ultrasonography: benign versus malignant lesions

An C, Rakhmonova G, Han K, Seo N, Lee JY, Kim MJ, Park MS

BACKGROUND/AIMS: To suggest a lexicon for liver ultrasonography and to identify radiologic features indicative of benign or malignant lesions on surveillance ultrasonography. METHODS: This retrospective study included 188 nodules (benign, 101;...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Role of Radiofrequency Ablation in Patients with Hepatocellular Carcinoma Who Undergo Prior Transarterial Chemoembolization: Long-Term Outcomes and Predictive Factors

Sohn W, Choi MS, Cho JY, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW, Yoo BC

BACKGROUND/AIMS: The role of radiofrequency ablation (RFA) remains uncertain in patients with viable hepatocellular carcinoma (HCC) after transarterial chemoembolization (TACE). METHODS: A total of 101 patients (April 2007 to August 2010)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Factors influencing hepatocellular carcinoma prognosis after hepatectomy: a single-center experience

Park SK, Jung YK, Chung DH, Kim KK, Park YH, Lee JN, Kwon OS, Kim YS, Choi DJ, Kim JH

BACKGROUND/AIMS: Recurrence after hepatic resection is one of the most important factors impacting the prognosis and survival of patients with hepatocellular carcinoma (HCC). We identified prognostic factors affecting overall survival...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation

Lee JY, Kim YH, Yi NJ, Kim HS, Lee HS, Lee BK, Kim H, Choi YR, Hong G, Lee KW, Suh KS

BACKGROUND/AIMS: The most commonly used immunosuppressant therapy after liver transplantation (LT) is a combination of tacrolimus and steroid. Basiliximab induction has recently been introduced; however, the most appropriate immunosuppression for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Spontaneous Neoplastic Remission of Hepatocellular Carcinoma

Kim SB, Kang W, Shin SH, Lee HS, Lee SH, Choi GH, Park JY

We report on a case of a 57-year-old male who underwent a curative resection for hepatocellular carcinoma (HCC) with histological confirmation of a spontaneously necrotized tumor. Initial serum AFP level...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr